ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.68
0.00%
US Tech 100
16,994.00
0.79%
S&P 500
5,018.39
-0.34%
US Dollar vs CAD
1.37171
-0.05%
Bitcoin
57,759.78
-0.82%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ESSA Pharma Inc (EPIX)

  7. ESSA Pharma Inc (EPIX) News

EPIX ESSA Pharma Inc

6.62
0.00 (0.00%)
Pre Market
Last Updated: 03:05:23
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
ESSA Pharma Inc EPIX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 6.62 03:05:23
Open Price Low Price High Price Close Price Previous Close
6.62
more quote information »

Recent News

Date Time Source Heading
4/09/202407:00PRNCAESSA Pharma to Present at the 2024 Bloom Burton & Co...
3/07/202419:13PRNUSESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING..
3/07/202416:18EDGAR2Form 8-K - Current report
3/05/202417:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202406:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/13/202406:01EDGAR2Form 8-K - Current report
2/13/202406:00PRNUSESSA Pharma Provides Corporate Update and Reports Financial..
2/07/202410:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202407:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202407:00PRNCAESSA Pharma to Present at the Oppenheimer 34th Annual..
1/29/202408:15EDGAR2Form 8-K - Current report
1/26/202415:40EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/26/202415:27EDGAR2Form DEF 14A - Other definitive proxy statements
1/25/202409:00PRNUSESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386)..
1/23/202415:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/17/202419:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/16/202415:19EDGAR2Form 144 - Report of proposed sale of securities
1/16/202412:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202415:04EDGAR2Form 144 - Report of proposed sale of securities
12/12/202306:01EDGAR2Form 8-K - Current report
12/12/202306:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/12/202306:00PRNCAESSA Pharma Provides Corporate Update and Reports Financial..
11/24/202310:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/21/202307:00PRNUSESSA Pharma to Present at the Piper Sandler 35th Annual..
11/08/202307:00PRNCAESSA Pharma to Present at the Jefferies London Healthcare..
11/06/202316:51PRNUSESSA Pharma Enters into At-The-Market Equity Offering Sales..
11/06/202315:57EDGAR2Form 8-K - Current report
10/26/202316:41PRNUSESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386)..
10/23/202315:19EDGAR2Form 8-K - Current report
10/21/202308:00PRNCAESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386)..
10/10/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
10/03/202315:35EDGAR2Form S-3/A - Registration statement under Securities Act of..
9/19/202315:43EDGAR2Form S-3 - Registration statement under Securities Act of..
9/18/202306:05EDGAR2Form 8-K - Current report
9/18/202306:00PRNUSESSA Pharma Announces Initiation of Phase 2 Study Evaluating..
8/31/202306:00PRNCAESSA Pharma Insiders Establish Automatic Securities..
8/08/202306:15EDGAR2Form 8-K - Current report
8/08/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202306:00PRNCAESSA Pharma Provides Corporate Update and Reports Financial..
6/06/202306:00PRNUSESSA Pharma Appoints Lauren Merendino to its Board of..
6/01/202306:00PRNUSESSA Pharma to Present at 2023 Jefferies Healthcare..
5/11/202306:00PRNCAESSA Pharma to Present at JMP Securities Life Sciences..
5/09/202306:00PRNUSESSA Pharma Provides Corporate Update and Reports Financial..

Your Recent History

NASDAQ
EPIX
ESSA Pharma
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved